Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R^-^/^-) mice (English)
- New search for: Poti, F.
- New search for: Costa, S.
- New search for: Bergonzini, V.
- New search for: Galletti, M.
- New search for: Pignatti, E.
- New search for: Weber, C.
- New search for: Simoni, M.
- New search for: Nofer, J. R.
- New search for: Poti, F.
- New search for: Costa, S.
- New search for: Bergonzini, V.
- New search for: Galletti, M.
- New search for: Pignatti, E.
- New search for: Weber, C.
- New search for: Simoni, M.
- New search for: Nofer, J. R.
In:
VASCULAR PHARMACOLOGY
;
57
, 1
;
56-64
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R^-^/^-) mice
-
Contributors:Poti, F. ( author ) / Costa, S. ( author ) / Bergonzini, V. ( author ) / Galletti, M. ( author ) / Pignatti, E. ( author ) / Weber, C. ( author ) / Simoni, M. ( author ) / Nofer, J. R. ( author )
-
Published in:VASCULAR PHARMACOLOGY ; 57, 1 ; 56-64
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2012-01-01
-
Size:9 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 612.13
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 612.13 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 57, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Expanding roles of glutamate receptors in neurovascular regulationAlexander, J. S. / Ganta, C. V. et al. | 2012
- 3
-
Hepatocyte growth factor stimulated angiogenesis without inflammation: Differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factorKaga, T. / Kawano, H. / Sakaguchi, M. / Nakazawa, T. / Taniyama, Y. / Morishita, R. et al. | 2012
- 10
-
Insights into gene therapy for critical limb ischemia: The devil is in the detailsMadonna, R. / Rokosh, G. et al. | 2012
- 15
-
An in vitro reconstitution system to address the mechanism of the vascular expression of the bradykinin B1 receptor in response to angiotensin converting enzyme inhibitionRoy, C. / Marceau, E. / Gera, L. / Marceau, F. et al. | 2012
- 24
-
Crosstalk between macrophages and smooth muscle cells in atherosclerotic vascular diseasesKoga, J. i. / Aikawa, M. et al. | 2012
- 29
-
Vascular effects of glycoprotein130 ligands - Part II: Biomarkers and therapeutic targetsDemyanets, S. / Huber, K. / Wojta, J. et al. | 2012
- 41
-
Relevance of new drug discovery to reduce NF-kB activation in cardiovascular diseaseMadonna, R. / De Caterina, R. et al. | 2012
- 48
-
Mesenchymal stem cell therapy for heart diseaseGnecchi, M. / Danieli, P. / Cervio, E. et al. | 2012
- 56
-
Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R^-^/^-) micePoti, F. / Costa, S. / Bergonzini, V. / Galletti, M. / Pignatti, E. / Weber, C. / Simoni, M. / Nofer, J. R. et al. | 2012
- e1
-
Graphical Abstracts Contents Listing| 2012
-
Editorial Board| 2012